We are live on ! Find out more
XGN icon

Exagen
XGN

53 hedge funds and large institutions have $64.1M invested in Exagen in 2025 Q2 according to their latest regulatory filings, with 22 funds opening new positions, 17 increasing their positions, 5 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

240% more repeat investments, than reductions

Existing positions increased: 17 | Existing positions reduced: 5

229% more call options, than puts

Call options by funds: $56K | Put options by funds: $17K

214% more first-time investments, than exits

New positions opened: 22 | Existing positions closed: 7

186% more capital invested

Capital invested by funds: $22.4M → $64.1M (+$41.7M)

39% more funds holding

Funds holding: 38 → 53 (+15)

7.25% more ownership

Funds ownership: 34.84% → 42.09% (+7.2%)

Holders
53
Holders Change
+15
Holders Change %
+39.47%
% of All Funds
0.7%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
22
Increased
17
Reduced
5
Closed
7
Calls
$56K
Puts
$17K
Net Calls
+$39K
Net Calls Change
+$87K

Top Buyers

Rank Fund Capital Flow
1
Balyasny Asset Management
Balyasny Asset Management
Illinois
+$4.37M
2
WC
Wexford Capital
Florida
+$2.53M
3
UBS Group
UBS Group
Switzerland
+$2.33M
4
Russell Investments Group
Russell Investments Group
United Kingdom
+$1.34M
5
FCM
FourWorld Capital Management
New York
+$1.27M

Top Sellers

Rank Fund Capital Flow
1
PCM
Perkins Capital Management
Minnesota
-$1.16M
2
Renaissance Technologies
Renaissance Technologies
New York
-$704K
3
Hudson Bay Capital Management
Hudson Bay Capital Management
Connecticut
-$598K
4
Marshall Wace
Marshall Wace
United Kingdom
-$383K
5
SCM
Stonepine Capital Management
Oregon
-$344K
Name Holding Trade Value Shares
Change 		Change in
Stake
Two Sigma Investments
26
Two Sigma Investments
New York
$440K +$383K +63,000 New
NCM
27
Nantahala Capital Management
Connecticut
$427K – – –
State Street
28
State Street
Massachusetts
$396K +$140K +23,100 +69%
BRF
29
B. Riley Financial
California
$349K +$304K +50,000 New
PM
30
Penbrook Management
New York
$280K +$121K +19,910 +51%
QC
31
Quadrature Capital
United Kingdom
$217K +$189K +31,055 New
Dimensional Fund Advisors
32
Dimensional Fund Advisors
Texas
$211K – – –
BCM
33
Bridgeway Capital Management
Texas
$194K +$15.8K +2,600 +10%
Goldman Sachs
34
Goldman Sachs
New York
$158K +$137K +22,602 New
Renaissance Technologies
35
Renaissance Technologies
New York
$147K -$704K -115,800 -85%
OQS
36
Occudo Quantitative Strategies
Florida
$138K +$120K +19,808 New
XT
37
XTX Topco
Cayman Islands
$133K +$116K +19,033 New
Northern Trust
38
Northern Trust
Illinois
$128K – – –
Corient Private Wealth
39
Corient Private Wealth
Florida
$102K – – –
Acadian Asset Management
40
Acadian Asset Management
Massachusetts
$87K +$34.1K +5,615 +80%
VF
41
Virtu Financial
New York
$70K +$61K +10,039 New
AF
42
Allworth Financial
California
$49K – – –
Royal Bank of Canada
43
Royal Bank of Canada
Ontario, Canada
$40K +$31.2K +5,139 +749%
Wells Fargo
44
Wells Fargo
California
$37.6K +$18.2K +3,000 +126%
Barclays
45
Barclays
United Kingdom
$35.9K – – –
Bank of America
46
Bank of America
North Carolina
$29.4K -$772 -127 -3%
TC
47
Truvestments Capital
Florida
$17.2K +$15K +2,471 New
Raymond James Financial
48
Raymond James Financial
Florida
$10.9K +$9.53K +1,568 New
Lazard Asset Management
49
Lazard Asset Management
New York
$8K +$7.29K +1,200 New
Osaic Holdings
50
Osaic Holdings
Arizona
$6.98K – – –
1
2
3

XGN Hedge Fund Activity: Q2 2025 in Review

53 of the 7,604 institutional investors tracked by Wall St. Rank reported a position in Exagen (XGN) for Q2 2025, worth a combined $64.1M — up 186% from $22.4M a quarter earlier.

Buyers outnumbered sellers: 22 funds opened new XGN positions and 7 closed out — a net gain of 15 holders — while 17 added to existing stakes and 5 trimmed.

The largest buyer was Balyasny Asset Management, opening a new position worth an estimated $4.37M. The largest seller was Perkins Capital Management, cutting an estimated $1.16M.

  • 53 institutional investors held Exagen (XGN) as of Q2 2025, up from 38 in Q1 2025.
  • Funds reported $64.1M of Exagen stock for Q2 2025, up 186% quarter-over-quarter.
  • 22 funds opened new Exagen positions in Q2 2025 and 7 closed out, a net change of +15 holders.
  • The largest Exagen buyer in Q2 2025 was Balyasny Asset Management, an estimated $4.37M added.
  • The largest Exagen seller in Q2 2025 was Perkins Capital Management, an estimated $1.16M sold.

Based on aggregated 13F filings for Q2 2025.